-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BReNSlN0Ac5f36+8X5QoJHEh4evSXGL4DGrs5yisbOKPZZEYZ73QjE67fzi2PXII eZlLMx5SvTqUKzF08raS6A== 0001181431-03-003213.txt : 20030221 0001181431-03-003213.hdr.sgml : 20030221 20030221170818 ACCESSION NUMBER: 0001181431-03-003213 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021231 FILED AS OF DATE: 20030221 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: CARUTHERS MARVIN H CENTRAL INDEX KEY: 0001167233 RELATIONSHIP: OTHER FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 03576482 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 6176737800 5 1 rrd5245.htm ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP SEC Form 5
FORM 5

[X] Check this box if no longer
subject to Section 16. Form 4 or Form 5 obligations may continue.
See Instruction 1(b).

[  ] Form 3 Holdings Reported

[  ] Form 4 Transactions Reported
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
OMB APPROVAL


OMB Number: 3235-0362
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 1.0
1. Name and Address of Reporting Person*
Caruthers, Marvin
(Last)                      (First)                      (Middle)
c/o OXiGENE, Inc.
321 Arsenal Street
(Street)
Watertown,    MA   02472
(City)                      (State)                      (Zip)
2. Issuer Name
and Ticker or Trading Symbol

OXiGENE, Inc.
OXGN
3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)
4. Statement for
    Month/Year

12/31/2002

5. If Amendment,
    Date of Original
    (Month/Year)
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

   Director      10% Owner
   Officer (give title below)     X Other (specify below)

Description           Former Director
7. Individual or Joint/Group
    Filing (Check Applicable Line)

X   Form filed by One Reporting Person
     Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)
2.Transaction
Date
(Month/Day/Year)
2A. Deemed Execution Date, if any
(Month/Day/Year)
 3. Transaction
    Code
    (Instr. 8) 		4. Securities Acquired (A) or Disposed Of (D)
    (Instr. 3, 4, and 5)



        Amount      /         A/D         /         Price          
5. Amount of
    Securities
    Beneficially
    Owned at end of
    Issuer's Fiscal Year

    (Instr. 3 and 4)
6. Owner-
    ship
    Form:
    Direct (D)
    or
    Indirect (I)

    (Instr. 4)
7. Nature of
     Indirect
     Beneficial
     Ownership

    (Instr. 4)
Common Stock
02/02/2002
A
80,000 / A / (1)
80,500 (2)
D
N/A
/ /
1,000 (2)
I
By Spouse as Trustee for Children
 
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction Date

(Month/
Day/
Year)
3A. Deemed Execution Date, if any

(Month/
Day/
Year)
 4. Transaction Code
    (Instr.8) 		5. Number of Derivative
    Securities Acquired (A)
    or Disposed Of (D)

    (Instr. 3, 4 and 5)




  A     or     D  
6. Date Exercisable(DE) and
    Expiration Date(ED)
    (Month/Day/Year)





  DE     /     ED  
7. Title and Amount of
    Underlying Securities
    (Instr. 3 and 4)





Title     /         Amount or Number of Shares
8. Price
    of
    Derivative
    Security
    (Instr.5)
 9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    at End of Year
    Reported
    Transaction(s)
    (Instr.4) 		10. Owner-
ship
Form of
Deriv-
ative
Securities:
Direct (D)
or
Indirect (I)

(Instr.4) 		11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr.4)
Option for Common Stock (right to buy) $10.00 (3) 02/02/2002
J (3)
 41,377 D
(4) / 6/14/2006
Common Stock / 41,377
N/A
0 (2)
D
N/A
Option for Common Stock (right to buy) $10.50 (3) 02/02/2002
J (3)
 18,623 D
(5) / 6/29/2009
Common Stock / 18,623
N/A
0 (2)
D
N/A
Option for Common Stock (right to buy) $7.25 (3) 02/02/2002
J (3)
 20,000 D
(6) / 11/13/2010
Common Stock / 20,000
N/A
0 (2)
D
N/A
Explanation of Responses:
 
(1) Acquired pursuant to an agreement with OXiGENE, Inc. (the "Company") for past services rendered to the Company.
(2) Reported as of June 11, 2002, the date that Mr. Caruthers' service as a director ended.
(3) At the election of Mr. Caruthers, the options were forfeited and cancelled as provided in the option agreement between Mr. Caruthers and the Company. Mr. Caruthers disclaims any obligation to report such forfeiture and cancellation of options and is reporting on this Form 5 voluntarily.
(4) The options become exercisable as follows: 16,552 on 6/14/97, 8,275 on 6/14/98, 8,275 on 6/14/99, and 8,275 on 6/14/00.
(5) The options become exercisable in five equal annual installments beginning 6/29/00.
(6) The options become exercisable in five equal annual installments beginning 11/13/01.
By: Date:
/s/ Marvin Caruthers 02/21/2003
** Signature of Reporting Person
SEC 2270 (09-02)


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB Number.
-----END PRIVACY-ENHANCED MESSAGE-----